BRCA1/BRCA2 Test (Hereditary Breast and Ovarian Cancer) in San Sebastián de la Gomera

Before undergoing the BRCA1 and BRCA2 genetic test for hereditary breast and ovarian cancer, it’s important that you meet certain criteria that may indicate the need for this test—such as being diagnosed with cancer at a young age or having a family history that suggests a possible inherited BRCA1 or BRCA2 mutation.

Mutations in the BRCA1 and BRCA2 genes are strongly associated with an increased risk of breast and ovarian cancer.

Women with a personal or family history of hereditary breast or ovarian cancer should receive medical guidance and consider testing to assess whether there is a genetic predisposition involved.

It’s also important to note that this test does not only assess the risk of breast cancer. In men, BRCA2 mutations can also increase the risk of developing prostate cancer.

Situations that may indicate the need for BRCA1 and BRCA2 Hereditary Cancer testing

The BRCA1 and BRCA2 genetic test may be recommended in the following cases:

• Women with family members diagnosed with breast, ovarian, fallopian tube, or peritoneal cancer
• Women who have been diagnosed with both breast and ovarian cancer
• Women diagnosed with breast cancer before the age of 50
• Women with two relatives diagnosed with breast cancer, at least one diagnosed before age 50 or with bilateral breast cancer
• Families with three or more cases of breast and/or ovarian cancer (including at least one ovarian cancer) among first- and second-degree relatives
• Women with two relatives (first- or second-degree) diagnosed with ovarian cancer
• Women with cancer in both breasts
• Women who have had multiple primary breast cancers
• Cases of male breast cancer
• A male relative with breast cancer and a female relative (first- or second-degree) with breast or ovarian cancer

Having any of these circumstances increases the probability of developing hereditary cancer due to a genetic mutation. However, it’s important to remember that meeting these criteria does not necessarily mean you will develop breast or ovarian cancer.

In cases where the test detects a pathogenic mutation in the BRCA1 and BRCA2 genes, it is necessary to expand the study. It is advisable to evaluate the family members of the affected patient to check if anyone else has a genetic change that increases the risk of developing breast and ovarian cancer.

It is important to know this because these individuals will enter high-risk prevention protocols or take prophylactic measures, which may include treatments and, in some cases, more radical measures such as mastectomy.

Operarme collaborates with Megalab Laboratories, where the BRCA1 and BRCA2 Test is performed. Therefore, if your medical or family history suggests a genetic mutation and you would like to undergo the BRCA1/BRCA2 (Hereditary Breast and Ovarian Cancer) Test, don’t hesitate to contact us by calling at +34 91 141 33 56, or by filling out the contact form.

Once you purchase the BRCA1 and BRCA2 (Hereditary Breast and Ovarian Cancer) test, you will receive a voucher by email. After downloading it, you can make an appointment at the Megalab sample collection center you selected on the website.

This test is a genetic examination that analyzes genes associated with hereditary or familial breast and ovarian cancer. To perform this medical test, you will need the following:

1. The BRCA1 and BRCA2 hereditary breast and ovarian cancer test is performed using a blood sample.
2. Before taking the test, the following documents are required: Medical referral or prescription and specific consent, including a clinical report, if necessary.
3. Results will be available in 30 business days after the test is conducted at the laboratory.
4. Genetic counseling with the specialist will be essential to assess the implications of the result for you and your family, if needed.

Both the blood draw and the telephone consultation with the genetic counselor are included in the price of the BRCA1 and BRCA2 hereditary breast and ovarian cancer test.

The test results will be available in 3-4 weeks after the test is conducted.

Once the genetic team processes your blood sample, they will explain how to access your results:

1. You will be provided with an access code to enter your private area.
2. From there, you can check the status of your results report.
3. If results are not yet available, the status will show as "pending".
4. Finally, you will be given the contact number of the laboratory where you had the test, should you have any questions while waiting for your results.

Genetic counseling becomes increasingly important once you have your test results.

Although the results will be explained in detail within the report, there is always the option of scheduling a genetic counseling consultation, which can be done via phone after the BRCA1 and BRCA2 test:

• The doctor will explain in more detail the medical implications of the result, both for you and for your family.
• If the test result is positive, the doctor will explain the risk of passing the mutation to your children. Additionally, if you have siblings (from the same parents), there is a 50% chance that they may also carry a BRCA1 or BRCA2 mutation.
• Based on the test result, the doctor will provide guidance on the next steps and action protocols.
• If the result is uncertain, genetic counseling will help clarify the different factors that may have influenced this outcome.

Ultimately, this consultation helps the patient understand the process and the significance of the information obtained from the test.

Operarme works in collaboration with the Eurofins Laboratory Canarias - San Sebastián de la Gomera: you can click, purchase, and schedule your genetic analysis.

If you have any questions regarding the test, feel free to contact us by calling at +34 91 141 33 56, or by filling out the contact form.